11 a 20 de 3.680 Resultados
Datos tabulares - 8,6 KB
|
Texto plano - 3,9 KB -
MD5: c299d7714b0817e353e887856a18340d
|
28 abr 2025
Porto, M Dolores, 2025, "Spanish news items on Syrian migration containing water metaphors", https://doi.org/10.21950/HLT2EI, e-cienciaDatos, V1
300 news items (150 from EL País and 150 from ABC) referring to Syrian migration in 2015 and 2016 containing water metaphors |
Datos tabulares - 18,0 KB
|
Texto plano - 2,7 KB -
MD5: 4a2ce8101f577c2fb9f8af1e1445a7fa
|
24 abr 2025
Larrubia Marfil, Juan Ramon; Fernandez Rodriguez, Conrado M; Barquero-Perez, Oscar, 2025, "Metformin reduces hepatocellular carcinoma risk in chronic hepatitis C with advanced fibrosis after SVR", https://doi.org/10.21950/UKPFJF, e-cienciaDatos, V1
The dataset comprises a database including 1556 chronic hepatitis C patients with sustained virologic response after treatment with direct acting antivirals. These patients have been followed up for a median of 74 months after development of hepatocelular carcinoma, death from ot... |
24 abr 2025 -
Metformin reduces hepatocellular carcinoma risk in chronic hepatitis C with advanced fibrosis after SVR
Adobe PDF - 58,4 KB -
MD5: 4941db957779356212b0fe85941c2a03
|
24 abr 2025 -
Metformin reduces hepatocellular carcinoma risk in chronic hepatitis C with advanced fibrosis after SVR
Binario SPSS - 242,8 KB -
MD5: fc518e697c204de678ca6f8ce1b1a3e6
|
24 abr 2025 -
Metformin reduces hepatocellular carcinoma risk in chronic hepatitis C with advanced fibrosis after SVR
Valores separados por comas - 307,4 KB -
MD5: 47abb34abb65e2fcedf9ccd64e8debc7
|
24 abr 2025 -
Metformin reduces hepatocellular carcinoma risk in chronic hepatitis C with advanced fibrosis after SVR
Texto plano - 6,0 KB -
MD5: 3846c81ba75a6c5fafd796c80a11f0d6
|